El Hospital de la Santa Cruz y San Pablo​​ está situado en un conjunto de edificios ubicados en Barcelona, proyectados por el arquitecto Lluís Domènech i Montaner, uno de los principales representantes del modernismo catalán.

During the past decade, Hospital de Sant Pau conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Sant Pau" #1 sponsor was "Hospital Clinic of Barcelona" with 7 trials, followed by "PETHEMA Foundation" with 7 trials sponsored, "Hospital Universitari Vall d'Hebron Research Institute" with 4 trials sponsored, "Parc de Salut Mar" with 3 trials sponsored and "Abbott Medical Devices" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Sant Pau" #1 collaborator was "Germans Trias i Pujol Hospital" with 3 trials as a collaborator, "Hospital Universitari de Bellvitge" with 3 trials as a collaborator, "Hospital de Sant Pau" with 3 trials as a collaborator, "Hospital del Mar" with 3 trials as a collaborator and "Complejo Hospitalario Universitario de Vigo" with 2 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Sant Pau" are "Acute Lymphoblastic Leukemia" (4 trials), "Atrial Fibrillation" (2 trials), "HIV Infections" (2 trials), "Hepatic Encephalopathy" (2 trials) and "Non Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Hospital de Sant Pau" in a lesser frequency.

Most popular intervention types in "Hospital de Sant Pau" are "Drug" (25 trials), "Device" (8 trials), "Procedure" (6 trials), "Other" (5 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Prednisone" (4 trials), "Vincristine" (4 trials), "Cyclophosphamide" (3 trials) and "Cytosine Arabinoside" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Sant Pau" are 44 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital de Sant Pau". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Hospital de Sant Pau, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Sant Pau, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 7 trials that are defined as “Not Applicable".